232 filings
8-K
LXRX
Lexicon Pharmaceuticals, Inc.
16 Sep 24
Departure of Directors or Certain Officers
6:51am
8-K
LXRX
Lexicon Pharmaceuticals, Inc.
1 Aug 24
Lexicon Pharmaceuticals Reports Second Quarter 2024
4:05pm
8-K
LXRX
Lexicon Pharmaceuticals, Inc.
8 Jul 24
Departure of Directors or Certain Officers
9:15am
8-K
LXRX
Lexicon Pharmaceuticals, Inc.
1 Jul 24
Entry into a Material Definitive Agreement
4:05pm
8-K
LXRX
Lexicon Pharmaceuticals, Inc.
10 May 24
Unregistered Sales of Equity Securities
4:15pm
8-K
8ugtnq6u 9swv9
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
8-K
emsnhb9
29 Apr 24
Departure of Directors or Certain Officers
9:00am
8-K
hxqfc qsysf
12 Mar 24
Material Modifications to Rights of Security Holders
4:31pm
8-K
akff0o4dipqr4esucker
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
tbrlazjgoemgbg pq12
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
h7p11mbp5q1rf8
29 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
47hvg5 y1
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
3r7ygnbu7pbs65vj
11 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
cvuri661iuazs 6h
3 Aug 23
Lexicon Pharmaceuticals Reports Second Quarter 2023
4:08pm
8-K
g2yune9v
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
8-K
m1c1hwt gtde3lndbz
24 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
4uqixg cz3qcy3jca
28 Jun 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:20pm
8-K
4bzguf3exgxon2rolgse
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
8-K
vkhig0xh4dhib9ysld5
31 May 23
Lexicon Announces Proposed Public Offering of Common Stock
4:17pm
8-K/A
slvho
8 May 23
Submission of Matters to a Vote of Security Holders
4:15pm